Middleton & CO Inc Gilead Sciences, Inc. Transaction History

Middleton & CO Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 25, 2019	SELL	$62.53 - $70.05 $220,730 - $247,276	-3,530 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $855,975 - $1.12 Million	-14,139 Reduced 80.02%	3,530 $221,000
Q3 2018 Oct 25, 2018	SELL	$71.28 - $78.92 $128,304 - $142,056	-1,800 Reduced 9.25%	17,669 $1.36 Million
Q2 2018 Jul 26, 2018	SELL	$64.88 - $75.68 $1.32 Million - $1.54 Million	-20,363 Reduced 51.12%	19,469 $1.38 Million
Q1 2018 May 04, 2018	SELL	$72.84 - $88.8 $2.25 Million - $2.74 Million	-30,824 Reduced 43.63%	39,832 $3 Million
Q4 2017 Jan 25, 2018	SELL	$71.15 - $83.52 $2.33 Million - $2.74 Million	-32,752 Reduced 31.67%	70,656 $5.06 Million
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $7.46 Million - $8.84 Million	103,408	103,408 $8.38 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Middleton & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Middleton & CO Inc with notifications on news.